Terpenoid ID | TKC206776 | |
Chirality | TKC113063 | |
Cell line | 9 | |
Protein target | 1 | |
DiseaseNCIT | 7 | |
ORDO | 1 | |
ICD | 21 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC206776 | B16-F10 | B16/F10; B16 F10; B16F10; B16 melanoma F10 | 290.0 | nM | IC50 | C21790 | |
TKC206776 | SK-MEL-28 | SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36 | 1000.0 | nM | IC50 | C3510 | |
TKC206776 | HeLa | HELA; Hela; He La; He-La; HeLa-CCL2; Henrietta Lacks cells; Helacyton gartleri | 2300.0 | nM | IC50 | C27677 | |
TKC206776 | Vero | VERO; VeroCCL81; Vero 81; Vero-81; Verda reno | 1300.0 | nM | IC50 | ||
TKC206776 | U-251 | U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6) | 690.0 | nM | IC50 | C60781 | Orphanet_94 |
TKC206776 | DU-145 | DU-145; Du-145; DU 145; DU_145; DU.145; Duke University 145 | 2500.0 | nM | IC50 | C4863 | |
TKC206776 | PC-3 | PC3; PC.3 | 410.0 | nM | IC50 | C4863 | |
TKC206776 | LNCaP | LNCAP; LNCap; Ln-Cap; Lymph Node Carcinoma of the prostate | 870.0 | nM | IC50 | C4863 | |
TKC206776 | HEK-293T | Hek293T; HEK-293T; HEK 293T; HEK-293-T; HEK 293 T; 293-T; 293 T; 293T; Human Embryonic Kidney 293T; 293tsA1609neo | 250.0 | nM | IC50 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC206776 | P31749 | RAC-alpha serine/threonine-protein kinase | AKT1 | 3 | uM | Activity |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P31749 | AKT1_HUMAN | Brain cancer [ICD-11: 2A00] |
P31749 | AKT1_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
P31749 | AKT1_HUMAN | Central nervous system disease [ICD-11: 8A04-8D87] |
P31749 | AKT1_HUMAN | Colorectal cancer [ICD-11: 2B91] |
P31749 | AKT1_HUMAN | Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P31749 | AKT1_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P31749 | AKT1_HUMAN | Prostate cancer [ICD-11: 2C82] |
P31749 | AKT1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P31749 | AKT1_HUMAN | Stomach cancer [ICD-11: 2B72] |
P31749 | AKT1_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P31749 | AKT1_HUMAN | Cardiovascular disease [ICD-11: BA00-BE2Z] |
P31749 | AKT1_HUMAN | Injury [ICD-11: NA00-ND5Z] |
P31749 | AKT1_HUMAN | Leukaemia [ICD-11: 2A60-2B33] |
P31749 | AKT1_HUMAN | Lymphoma [ICD-11: 2A80-2A86] |
P31749 | AKT1_HUMAN | Multiple myeloma [ICD-11: 2A83] |
P31749 | AKT1_HUMAN | Ovarian cancer [ICD-11: 2C73] |
P31749 | AKT1_HUMAN | Overgrowth syndrome [ICD-11: LD2C] |
P31749 | AKT1_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P31749 | AKT1_HUMAN | Parkinsonism [ICD-11: 8A00] |
P31749 | AKT1_HUMAN | Renal cell carcinoma [ICD-11: 2C90] |
P31749 | AKT1_HUMAN | Arterial occlusive disease [ICD-11: BD40] |